Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
NCT ID | NCT02759588 |
Title | GL-ONC1 Oncolytic Immunotherapy in Patients With Recurrent Ovarian Cancer |
Recruitment | Completed |
Gender | female |
Phase | Phase Ib/II |
Variant Requirements | No |
Sponsors | Genelux Corporation |
Indications | |
Therapies | |
Age Groups: | adult | senior |
Covered Countries | USA |